A detailed history of Deka Bank Deutsche Girozentrale transactions in Bio N Tech Se stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 481,397 shares of BNTX stock, worth $54.9 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
481,397
Previous 427,597 12.58%
Holding current value
$54.9 Million
Previous $34.5 Million 64.73%
% of portfolio
0.11%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$78.36 - $124.66 $4.22 Million - $6.71 Million
53,800 Added 12.58%
481,397 $56.9 Million
Q2 2024

Aug 08, 2024

BUY
$80.36 - $102.87 $1.26 Million - $1.62 Million
15,700 Added 3.81%
427,597 $34.5 Million
Q1 2024

Apr 24, 2024

SELL
$88.96 - $112.35 $1.17 Million - $1.48 Million
-13,174 Reduced 3.1%
411,897 $38.3 Million
Q4 2023

Jan 24, 2024

BUY
$90.91 - $112.75 $11.6 Million - $14.4 Million
127,951 Added 43.06%
425,071 $44.6 Million
Q3 2023

Nov 13, 2023

SELL
$98.5 - $125.08 $1.63 Million - $2.07 Million
-16,551 Reduced 5.28%
297,120 $30.2 Million
Q2 2023

Jul 25, 2023

BUY
$102.58 - $129.66 $6.91 Million - $8.73 Million
67,315 Added 27.32%
313,671 $33.8 Million
Q1 2023

Apr 24, 2023

SELL
$122.57 - $153.67 $787,389 - $987,176
-6,424 Reduced 2.54%
246,356 $29.7 Million
Q4 2022

Feb 01, 2023

SELL
$118.43 - $186.05 $3.81 Million - $5.98 Million
-32,159 Reduced 11.29%
252,780 $38.9 Million
Q3 2022

Nov 02, 2022

SELL
$127.65 - $183.11 $4.62 Million - $6.63 Million
-36,181 Reduced 11.27%
284,939 $38 Million
Q2 2022

Aug 03, 2022

BUY
$123.25 - $186.24 $1.49 Million - $2.25 Million
12,085 Added 3.91%
321,120 $46.4 Million
Q1 2022

Apr 28, 2022

BUY
$126.25 - $231.85 $12.1 Million - $22.3 Million
96,039 Added 45.09%
309,035 $54.1 Million
Q4 2021

Feb 02, 2022

BUY
$216.64 - $362.52 $7.47 Million - $12.5 Million
34,500 Added 19.33%
212,996 $51.7 Million
Q3 2021

Oct 22, 2021

SELL
$205.93 - $447.23 $11.4 Million - $24.7 Million
-55,181 Reduced 23.61%
178,496 $50.1 Million
Q2 2021

Aug 05, 2021

SELL
$113.32 - $241.49 $28.2 Million - $60.1 Million
-248,700 Reduced 51.56%
233,677 $52.8 Million
Q1 2021

Apr 28, 2021

BUY
$85.73 - $119.5 $29.8 Million - $41.6 Million
348,124 Added 259.3%
482,377 $52.1 Million
Q4 2020

Mar 12, 2021

SELL
$72.71 - $129.54 $8.05 Million - $14.3 Million
-110,747 Reduced 45.2%
134,253 $12 Million
Q3 2020

Oct 29, 2020

BUY
$57.81 - $104.17 $8.16 Million - $14.7 Million
141,200 Added 136.03%
245,000 $16.6 Million
Q2 2020

Aug 04, 2020

BUY
$38.58 - $66.74 $1.69 Million - $2.92 Million
43,800 Added 73.0%
103,800 $6.87 Million
Q1 2020

May 14, 2020

SELL
$28.55 - $92.0 $6.2 Million - $20 Million
-217,000 Reduced 78.34%
60,000 $3.62 Million
Q4 2019

Feb 04, 2020

BUY
$12.75 - $36.91 $3.53 Million - $10.2 Million
277,000 New
277,000 $9.46 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.7B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.